Medical Xpress

Visual analog scale has comparable validity for perennial allergic, nonallergic rhinitis

The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study ...
ascopubs.org

Visual analog scale (VAS) and time trade-off (TTO) preferences for side effects (SE) of chemoradiation (chemoXRT): A comparison of patients (pts) and caregivers (CG).

Vanderbilt Head and Neck Symptom Survey Version 2.0 (VHNSS 2.0): A tool for the study of long-term oral health consequences of therapy for head and neck cancer (HNC). Background: CG provide clinicians ...
Medscape

Development and Psychometric Testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS)

The expert panel agreed that the VAS-IBS gives a good picture of how a patient with IBS might feel, and all members except one thought that the VAS-IBS might be useful in clinical practice. Agreement ...
Ophthalmology Times

FDA Type C meeting supports phase 2b/3 pathway for urcosimod in neuropathic corneal pain

The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...

OKYO Pharma clears key FDA meeting for Urcosimod Phase 2b/3 Trial

OKYO Pharma’s new CEO Robert Dempsey joined Steve Darling from Proactive to announce that the company has completed a ...